StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $0.39 | $0.40 | +2.56% | 0.4M |
| 05-12 | $0.39 | $0.39 | +0.34% | 0.1M |
| 05-13 | $0.38 | $0.32 | -16.21% | 1.9M |
| 05-14 | $0.31 | $0.35 | +10.51% | 0.3M |
| 05-15 | $0.34 | $0.34 | +1.25% | 0.1M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
No sell-side coverage available for ALBT.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for ALBT.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
| Metric | Annual 2025 2025-12-12 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $0.00 | $1.05M | $700.21K | $349.80K |
Operating Income | Not available | $-5.77M | $-5.69M | $-1.79M |
Net Income | $94.45K | $-16.19M | $-15.94M | $-2.48M |
EPS (Diluted) | Not available | $-6.10 | $-8.33 | $-1.43 |
Total Assets | Not available | $9.13M | $7.99M | $10.61M |
Total Liabilities | Not available | $13.62M | $15.10M | $14.50M |
Cash & Equivalents | Not available | $333.93K | $201.53K | $1.37M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 4.10M | 2.35M | 1.65M |
Avalon Globocare Corp is a technology driven company with a focus on developing products and services that serve growing consumer health and technology markets. Through its AI-driven subsidiary, the company is advancing next-generation AI systems, including automated video generation, enterprise documentation, and workflow automation solutions. Its segments consist of a consumer health technology segment, through which it distributes the Keto Air breathalyzer device, a non-invasive consumer breathalyzer that measures ketosis levels and is sold in North America; and an artificial intelligence content technology segment, through which it develops and commercializes an AI-driven, short-form video generation platform.